Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 150

1.

Ascertainment of individual risk of mortality for patients with idiopathic pulmonary fibrosis.

du Bois RM, Weycker D, Albera C, Bradford WZ, Costabel U, Kartashov A, Lancaster L, Noble PW, Raghu G, Sahn SA, Szwarcberg J, Thomeer M, Valeyre D, King TE Jr.

Am J Respir Crit Care Med. 2011 Aug 15;184(4):459-66. doi: 10.1164/rccm.201011-1790OC.

PMID:
21616999
2.

Marginal decline in forced vital capacity is associated with a poor outcome in idiopathic pulmonary fibrosis.

Zappala CJ, Latsi PI, Nicholson AG, Colby TV, Cramer D, Renzoni EA, Hansell DM, du Bois RM, Wells AU.

Eur Respir J. 2010 Apr;35(4):830-6. doi: 10.1183/09031936.00155108. Epub 2009 Oct 19.

3.

A multidimensional index and staging system for idiopathic pulmonary fibrosis.

Ley B, Ryerson CJ, Vittinghoff E, Ryu JH, Tomassetti S, Lee JS, Poletti V, Buccioli M, Elicker BM, Jones KD, King TE Jr, Collard HR.

Ann Intern Med. 2012 May 15;156(10):684-91. doi: 10.7326/0003-4819-156-10-201205150-00004.

PMID:
22586007
4.

Forced vital capacity in patients with idiopathic pulmonary fibrosis: test properties and minimal clinically important difference.

du Bois RM, Weycker D, Albera C, Bradford WZ, Costabel U, Kartashov A, King TE Jr, Lancaster L, Noble PW, Sahn SA, Thomeer M, Valeyre D, Wells AU.

Am J Respir Crit Care Med. 2011 Dec 15;184(12):1382-9. doi: 10.1164/rccm.201105-0840OC. Epub 2011 Sep 22.

PMID:
21940789
5.

Clinical and functional outcomes in Middle Eastern patients with idiopathic pulmonary fibrosis.

Alhamad EH, Masood M, Shaik SA, Arafah M.

Clin Respir J. 2008 Oct;2(4):220-6. doi: 10.1111/j.1752-699X.2008.00070.x.

PMID:
20298338
6.

Relative versus absolute change in forced vital capacity in idiopathic pulmonary fibrosis.

Richeldi L, Ryerson CJ, Lee JS, Wolters PJ, Koth LL, Ley B, Elicker BM, Jones KD, King TE Jr, Ryu JH, Collard HR.

Thorax. 2012 May;67(5):407-11. doi: 10.1136/thoraxjnl-2011-201184. Epub 2012 Mar 17.

PMID:
22426899
7.

Pulmonary hypertension as a prognostic indicator at the initial evaluation in idiopathic pulmonary fibrosis.

Kimura M, Taniguchi H, Kondoh Y, Kimura T, Kataoka K, Nishiyama O, Aso H, Sakamoto K, Hasegawa Y.

Respiration. 2013;85(6):456-63. doi: 10.1159/000345221. Epub 2012 Dec 19.

PMID:
23257350
8.

BUILD-3: a randomized, controlled trial of bosentan in idiopathic pulmonary fibrosis.

King TE Jr, Brown KK, Raghu G, du Bois RM, Lynch DA, Martinez F, Valeyre D, Leconte I, Morganti A, Roux S, Behr J.

Am J Respir Crit Care Med. 2011 Jul 1;184(1):92-9. doi: 10.1164/rccm.201011-1874OC. Epub 2011 Apr 7.

PMID:
21474646
9.

Association of hospital admission and forced vital capacity endpoints with survival in patients with idiopathic pulmonary fibrosis: analysis of a pooled cohort from three clinical trials.

Durheim MT, Collard HR, Roberts RS, Brown KK, Flaherty KR, King TE Jr, Palmer SM, Raghu G, Snyder LD, Anstrom KJ, Martinez FJ; IPFnet investigators.

Lancet Respir Med. 2015 May;3(5):388-96. doi: 10.1016/S2213-2600(15)00093-4. Epub 2015 Apr 15.

10.

Prognostic factors for idiopathic pulmonary fibrosis: clinical, physiologic, pathologic, and molecular aspects.

Lee SH, Shim HS, Cho SH, Kim SY, Lee SK, Son JY, Jung JY, Kim EY, Lim JE, Lee KJ, Park BH, Kang YA, Kim YS, Kim SK, Chang J, Park MS.

Sarcoidosis Vasc Diffuse Lung Dis. 2011 Oct;28(2):102-12.

PMID:
22117501
11.

Coexistent emphysema delays the decrease of vital capacity in idiopathic pulmonary fibrosis.

Akagi T, Matsumoto T, Harada T, Tanaka M, Kuraki T, Fujita M, Watanabe K.

Respir Med. 2009 Aug;103(8):1209-15. doi: 10.1016/j.rmed.2009.02.001. Epub 2009 Feb 28.

12.

Health-related quality of life does not predict mortality in idiopathic pulmonary fibrosis.

Nishiyama O, Taniguchi H, Kondoh Y, Kimura T, Kataoka K, Nishimura K, Ogawa T, Watanabe F, Arizono S, Tohda Y.

Sarcoidosis Vasc Diffuse Lung Dis. 2012 Oct;29(2):113-8.

PMID:
23461073
13.

Pulmonary hypertension in idiopathic pulmonary fibrosis: prevalence and clinical progress.

Castria D, Refini RM, Bargagli E, Mezzasalma F, Pierli C, Rottoli P.

Int J Immunopathol Pharmacol. 2012 Jul-Sep;25(3):681-9.

PMID:
23058018
14.

6-Minute walk distance is an independent predictor of mortality in patients with idiopathic pulmonary fibrosis.

du Bois RM, Albera C, Bradford WZ, Costabel U, Leff JA, Noble PW, Sahn SA, Valeyre D, Weycker D, King TE Jr.

Eur Respir J. 2014 May;43(5):1421-9. doi: 10.1183/09031936.00131813. Epub 2013 Dec 5.

15.

Idiopathic pulmonary fibrosis: a composite physiologic index derived from disease extent observed by computed tomography.

Wells AU, Desai SR, Rubens MB, Goh NS, Cramer D, Nicholson AG, Colby TV, du Bois RM, Hansell DM.

Am J Respir Crit Care Med. 2003 Apr 1;167(7):962-9.

PMID:
12663338
16.

Pulmonary function measures predict mortality differently in IPF versus combined pulmonary fibrosis and emphysema.

Schmidt SL, Nambiar AM, Tayob N, Sundaram B, Han MK, Gross BH, Kazerooni EA, Chughtai AR, Lagstein A, Myers JL, Murray S, Toews GB, Martinez FJ, Flaherty KR.

Eur Respir J. 2011 Jul;38(1):176-83. doi: 10.1183/09031936.00114010. Epub 2010 Dec 9.

17.

A simple assessment of dyspnoea as a prognostic indicator in idiopathic pulmonary fibrosis.

Nishiyama O, Taniguchi H, Kondoh Y, Kimura T, Kato K, Kataoka K, Ogawa T, Watanabe F, Arizono S.

Eur Respir J. 2010 Nov;36(5):1067-72. doi: 10.1183/09031936.00152609. Epub 2010 Apr 22.

18.

Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials.

Noble PW, Albera C, Bradford WZ, Costabel U, Glassberg MK, Kardatzke D, King TE Jr, Lancaster L, Sahn SA, Szwarcberg J, Valeyre D, du Bois RM; CAPACITY Study Group.

Lancet. 2011 May 21;377(9779):1760-9. doi: 10.1016/S0140-6736(11)60405-4. Epub 2011 May 13.

PMID:
21571362
19.

[A retrospective cohort study of prognostic factors for death in patients with idiopathic pulmonary fibrosis].

Li ZH, Peng SC, Kang J, Hou XM, Yu RJ.

Zhonghua Jie He He Hu Xi Za Zhi. 2010 Dec;33(12):887-91. Chinese.

PMID:
21211406
20.

Idiopathic pulmonary fibrosis: prognostic value of changes in physiology and six-minute-walk test.

Flaherty KR, Andrei AC, Murray S, Fraley C, Colby TV, Travis WD, Lama V, Kazerooni EA, Gross BH, Toews GB, Martinez FJ.

Am J Respir Crit Care Med. 2006 Oct 1;174(7):803-9. Epub 2006 Jul 6.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk